Home

HealthTopics

Health Centers

Reference Library

Search   Advanced

Darrell Hulisz, RPh, PharmD Associate Professor Department of Family Medicine University Hospitals School of Medicine Case Western Reserve University

Answers questions in the following forums:

• Pharmacy and Medications

NetWellness Articles associated with this Author:

	Article Name	Forum
	Seasonal Affective Disorder	Anxiety and Stress Disorders
	Sinus Headaches	Allergies
	Difference Between Shelf Life and Expiration Date of a Medication	Pharmacy and Medications

Programs:

• Resident Physician Education
  
  • Director, Pharmacotherapeutics Curriculum, Family Medicine Residency Program, University Hospitals of Cleveland (12 contact hours/year), 2004 to present
  • Lecturer, Inpatient Service Didactic Series, Family Medicine Residency Program, University Hospitals of Cleveland, 1994 to present
  • Lecturer, Family Medicine Core Conference Series (Substance Abuse Primer, Analgesics, Medical Informatics, Antimicrobials), 1995 to present
  • Lecturer, Women’s Health Conference Series, Family Medicine Residency Program, University Hospitals of Cleveland (osteoporosis, teratogenicity, HRT), 1996 to present
• Medical Student Education
  
  • Sponsor, Type B Elective, Case Western Reserve University, School of Medicine FAMD 001 - Family Practice Inpatient Service Acting Internship, 1996 to present
  • Sponsor, Type A Elective, Case Western Reserve University, School of Medicine FAMD 2006 Pharmacotherapeutics: Selected Topics in Drug Therapy for Family Practice (offered since 1995, except for academic year 2002-03), 1995 to present
  • Lecturer, Core Primary Care Clerkship (Combined Internal Medicine-Family Medicine-Psychiatry) for Third-Year Medical Students, Case Western Reserve University, College of Medicine (Antimicrobial agents), 2000 to present
  • Lecturer, Core Family Medicine Clerkship, Case Western Reserve University School of Medicine (Antihypertensive agents, Antibiotics, Prescription Writing), 1995 to 2000
• Pharmacy Student Education
  
  • Preceptor, Doctor of Pharmacy Advanced Practice Rotation in Ambulatory Care PHPR 650-02, Ohio Northern University College of Pharmacy (required rotation), 1994 to present
  • Preceptor, Doctor of Pharmacy Advanced Practice Rotation in Geriatrics, PHPR 650-04, Ohio Northern University College of Pharmacy (required rotation), 1994 to present
  • Preceptor, Doctor of Pharmacy Advanced Practice Rotation in Substance Abuse PHPR 650-53, Ohio Northern University College of Pharmacy (elective rotation), 2001
  • Lecturer, BSPC 543 Central Nervous System Module, Ohio Northern University College of Pharmacy (antidepressants, panic disorder, anxiety disorder), 2001 to present
  • Lecturer, BSPC 546 Capstone in Pharmacy Module, Ohio Northern University College of Pharmacy (substance abuse primer), 2003 to present
• Dentistry Student Education
  
  • Course Director, DEND 349 Clinical Pharmacology for Dentistry, Case Western Reserve University, School of Dentistry (required third year course), 2002 to 2005

Education:

• Doctor of Pharmacy, Medical University of South Carolina
• Bachelor of Science Pharmacy, University of Toledo

Post Graduate Training:

• Fellowship, Interdisciplinary Faculty Development
  • Health Resources and Services Administration
  • U.S. Department of Health and Human Services (multi-agency)
  • Association for Medical Education and Research in Substance Abuse (AMERSA)
  • Substance Abuse and Mental Health Service Administration (SAMHSA)

Licensure or Certification:

• Ohio Board of Pharmacy, 1989 to present
• South Carolina Board of Pharmacy, 1987 to present

Affiliations:

• Lexi-Comp
  
  • Member, Editorial Advisory Panel, Drug Information Handbook & Pediatrics Online, 2003 to present.
• American College of Clinical Pharmacy (ACCP):
  
  • Member, 1991 to present
  • Chair, Membership Committee 1993-1995
  • Clinical Practice Affairs Committee 1997-2000
• Society for Teachers of Family Medicine (STFM)
  
  • Member, 1999 to present
  • Committee Member, STFM Group on Pharmacotherapy, 2002 to present
• American Society of Health-System Pharmacists (ASHP)
  
  • Member, 1989 to present
  • Reviewer, ASHP 2002 Midyear Clinical Meeting, Platform Presentation Sessions, 2002 to present
• Northeastern Ohio Chapter of the Christian Medical and Dental Associations
  
  • Advisory Council Member, 1998 - 2001
• Ohio College of Clinical Pharmacy
  
  • Member, 1996 to present
• Case Western Reserve University
  
  • Advisor, Student Chapter, Christian Medical Association (CMA), 1998 to present
• University Hospitals Heath System
  
  • Member, QualChoice HMO Pharmacy and Therapuetics Committee, 1999 to 2003
  • Member, Pharmacy and Therapeutics Committee: Formulary Review Committee, 1999 to present
  • Member, Pharmacy and Therapeutics Committee: Medication Use and Assessment Subcommittee, 1997 to present
• Departmemt of Family Medicine at Case
  
  • Chair, Department of Family Medicine, Research Seed Grant Subcommittee, 2003 to present
  • Member, Department of Family Medicine, Committee on Appointments, Promotion, and Tenure, 2002 to present
  • Member, Residency Education Curriculum Committee, 1988 to present
  • Member, Practice Management Committee, Family Medicine Center, 1995 to present
• Medscape
  Author / Contributor Medscape by WebMD "Viewpoint" column "Ask-the-Expert" column CME/CE
• Regional Director for Experiential Education, Northeastern Ohio Region, Ohio Northern University College of Pharmacy

Partial List of Publications:

• Hulisz DT, Komara J. What pharmacists need to know about fibromyalgia. US Pharmacist 2006;1:HS-14-22.
• Hulisz DT. The efficacy of zinc against common cold viruses: An overview. Journal of the American Pharmaceutical Association 2004;44(5):594-603.
• Hulisz DT. The burden of illness of irritable bowel syndrome: treatment challenges and hope for the future. Journal of Managed Care Pharmacy 2004;10(4):299-309.
• Hulisz DT. Oral medications for diabetes mellitus. Pharmacy Times 2003;(10):48-50.
• Hulisz DT. Nonprescription treatment for acne vulgaris. Pharmacy Times 2003;(9):62-5.
• Hulisz DT. Facts from your pharmacist: urinary incontinence. Pharmacy Times, August 2003 (insert).
• Hulisz DT. Dietary supplementsfor weight loss: buyer beware. Pharmacy Times 2003;(7):40-42.
• Hulisz DT. Lipid disorders: a step-by-step approach to patient management. Pharmacy Times 2003(7):CV5-CV7.
• Horn JR, Hulisz DT. Pharmacists’ role in recognizing and managing patients with irritable bowel syndrome. Pharmacy Times 2003;(7):55-65.
• Hulisz DT. Facts form your pharmacist: Seasonal affective disorder, Pharmacy Times September 2002 (insert).
• Hulisz DT. Facts from your pharmacist: Sinus headache. Pharmacy Times, July 2002 (insert).
• Hulisz DT. Nonprescription medication use in pregnancy. Pharmacy Times 2002;68(6):17-22.
• Hulisz DT. Managing anemia in the hospitalized patient. US Pharmacist 2002;27:HS-61-HS68.
• Hulisz DT. Facts from your pharmacist: Medication advice for travelers. Pharmacy Times May 2002 (insert).
• Hulisz DT, Aouad J. Treatment of urinary incontinence. Pharmacy Times 2002;68(3):40-43.
• Hulisz DT. The hospital pharmacist and the medication history interview. US Pharmacist 2002;27(1):HS10-17.
• Hulisz DT. OTC products to alleviate insomnia. Pharmacy Times 2002;68(1):44-48.
• Hulisz DT. Symptomatic treatment of the common cold and influenza. Pharmacy Times 2001;67(10):52-56.
• Hulisz DT. OTC focus: The pharmacist's guide to vitamins. Pharmacy Times 2001;67(9):47-54.
• Hulisz DT. No bones about it: prevention and treatment of osteoporosis. Pharmacy Times 2001;67(8):23-4.
• Hulisz DT, Rai P. Counseling focus: Osteoporosis prevention and treatment. Pharmacy Times 2001;67(6):50-57.
• Hulisz DT. Safety and efficacy of glucosamine and chondroitin in osteoarthritis. US Pharmacist 2001;26(5):58-63.
• Hulisz DT, Strayer BE. Power over panic disorder. Pharmacy Times 2001;67(2):67-74.
• Hulisz DT. Book review: Handbook of nonprescription drugs, 12th edition. Journal of Pharmaceutical Technology 2001;246.
• Hulisz DT. Rx focus: Treatment for irritable bowel syndrome. Pharmacy Times 2001;67(1):10-16
• Hulisz DT, Bonfiglio MF. Metformin-associated lactic acidosis. Journal of the American Board of Family Practice 1998;11:233-6.
• Bonfiglio MF, Traeger SM, Kier K, Martin BF, Hulisz DT, Verbeck. Thrombocytopenia in intensive care patients: analysis of risk factors in 314 patients. The Annals of Pharmacotherapy 1995;29:835-42.
• Heiselman DE, Hulisz DT, Fricker R, Bredle DL, Black LD. Randomized comparison of gastric pH control with intermittent and continuous intravenous infusion of famotidine in ICU patients. American Journal of Gastroenterology 1995; 90:277-9.
• Hulisz DT, Dasa S, Black LD, Heiselman DE. Complete heart block and torsades de pointes associated with thioridazine poisoning. Pharmacotherapy 1994;14:239-45.
• Hagley MT, Hulisz DT, Burns CF. Hepatotoxicity associated with angiotensin converting-enzyme inhibitors. Annals of Pharmacotherapy 1993;27:228-31.
• Hulisz DT, Welko J, Heiselman DE. Sinus arrest associated with continuous infusion cimetidine. Pharmacotherapy 1993;13:64-7.
• Hagley MT, Benak RL, Hulisz DT. Suspected cross-reactivity of enalapril- and captopril-induced hepatotoxicity. Annals of Pharmacotherapy 1992;26:782-3.
• Hulisz DT, File TM. Predisposing factors and antibiotic usage in nosocomial infections caused by Xanthomonas maltophilia. Infection Control and Hospital Epidemiology 1992;13:489-90.
• Bonfiglio MF, Hulisz DT, Traeger SM, Martin BF. Hematologic effects of Histamine H2-receptor antagonists in intensive care patients. Pharmacotherapy 1992;12:265-6.
• Hagley MT, Hosney IA, Hulisz DT, Davis HH. Hemolytic-uremic syndrome associated with ingestion of quinine. American Journal of Nephrology 1992;12:192-5.
• Traeger SM, Bonfiglio MF, Hulisz DT, Martin BF. Anaphylactoid reaction to intravenous N-acetylcysteine associated with electrocardiographic abnormalities. Annals of Pharmacotherapy 1992;26:22-5.
• Brown RL, Dimond AR, Hulisz DT, Saunders LA, Bobula JA. Pharmacoepidemiology of potential alcohol-prescription drug interactions among primary care patients with alcohol use disorders. Journal of the American Pharmacists Association 2007;47:135-9.
• Bonder BR, Hulisz DT, Marsh S, Bonaguro J. Community-based substance abuse training: helping children living in families with substance abusing adults. Substance Abuse 2006;26(3/4):27-30.
• Hulisz DT, Short A, Pupillo M. Supplements for prostate health. US Pharmacist 2008;3:8-11
• Hulisz DT, Moore N. Chronic pain management. Role of newer antidepressants and anticonvulsants. US Pharmacist 2007;5:55-61.
• Hulisz DT, Jakab J. Food-drug interactions. Which ones really matter? US Pharmacist 2007;3:93-98.
• Hulisz DT, Henak B. Drug-induced osteoporosis: effects of medications on bone density. US Pharmacist 2006;12:HS3-HS6.
• Hulisz DT, Kovacevic D. Preventing heart disease in patients with diabetes. Diabetes Today 2006:11:15-18.
• Bonder BR, Hulisz DT, Marsh S, Bonaguro J. An interactive, electronic instructional unit on substance abuse. The Journal of Allied Health 2006;35(3):e215-226
• Hulisz DT, Tucker EM. What pharmacists need to know about shingles. US Pharmacist 2006;4:44-50.
• Hulisz DT, Fischer PJ. Psychopharmacology (Chapter 11). In: Bonder B (Ed) Psychopathology and Function, Third Edition, Slack Publishing, Inc. Thorofare, NJ, 2004:175-205.
• Hulisz DT. Can topiramate attenuate psychotropic-induced weight gain? Medscape Viewpoint. Posted October 1, 2008.
• Hulisz DT. Are osteoporosis risks being overlooked? Medscape Viewpoint. Posted August 15, 2008.
• Hulisz DT. Can pharmacists improve the accuracy of medication histories? Medscape Viewpoint. Posted August 13, 2008
• Hulisz DT. Patient assessment tool helps identify drug-related problems. Medscape Viewpoint. Posted July 10, 2008.
• Hulisz DT. Do tanning beds affect transdermal patches? Medscape Ask-the-Expert. Posted May 5, 2008.
• Hulisz DT. Are topical patches safe during MRI or CT scans? Medscape Ask-the-Expert. Posted May 5, 2008.
• Hulisz DT, Linderg K. The skinny on weight loss supplements: fact or fantasy? Medscape CME/CE. Posted May 9, 2008.
• Hulisz DT. Should patients with asthma receive beta-blockers for heart problems? Medscape Ask-the-Expert. Posted January 31, 2008
• Hulisz DT. Top herbal products: efficacy & safety concerns. Medscape CME/CE. Posted January 4, 2008.
• Hulisz DT. Which statin is right for my patient? Medscape Ask-the-Expert. Posted August 28, 2007.
• Hulisz DT. Furosemide resistance in heart failure patients. Medscape Ask-the-Expert. Posted August 3, 2007
• Hulisz DT. Is it safe to order drugs from overseas pharmacies? Medscape Ask-the-Expert. Posted January 2, 2009
• Hulisz DT, Lagzdins M. Drug-induced hypertension. US Pharmacist 2008:833(9):HS11-HS20.
• Hulisz DT. Should insulin therapy be adjusted for a cardiac stress test? Medscape Ask-the-Expert. Posted May 20, 2009
• Hulisz D, Duff C. Assisting seniors with insomnia: a comprehensive approach.US Pharmacist 2009;6:38-44.

Research:

• Consultant: Primary practice program for patients with chronic pain (4PCP), Chelimisky T (PI), Funding Agency: Macy Foundation, 2004-2007
• Principle Investigator: Interdisciplinary education on substance abuse: development of an electronic, interactive educational unit for pharmacists, physicians, and allied health professionals. Funded by Health Resources and Services Administration (HRSA), and the Association for Medical Education and Research in Substance (AMERSA), and the Substance Abuse and Mental Health Service Administration (SAMHSA), 2002-2004
• Principle Investigator: Randomized, double-blind, placebo-controlled trial of amino acid-chelated zinc acetate 10% in treating common cold symptoms in children and adults. University Family Medicine Foundation, University Hospitals Health System Research Institute, Improvita Inc., 1998-2001
• Principle Investigator: A 52-week, double-blind, randomized, placebo-controlled, multicenter trial to evaluate the efficacy of orlistat (Ro 18-0647) plus diet in obese hypertensive patients inadequately controlled with antihypertensive medications. University Family Medicine Foundation, University Hospitals Health System Research Institute, Roche Pharmaceuticals, 1998 – 2000
• Co-Investigator: Antihypertensive and lipid-lowering therapy to prevent heart attack trail (ALLHAT), National Institutes of Health, NHLBI, Department of Veterans Affairs Administration, Case Western Reserve University, Department of Family Medicine, 1995-2002
• Co-Investigator: Glucosamine use among primary care patients. Health Resources and Services Administration (HRSA) Title VII Grant, Department of Family Medicine, University Hospitals, Case Medical Center
• Co-investigator: Absorption of a rapidly disintegrating low-dose aspirin formulation from the oral cavity. Department of Pharmaceutical Sciences, Ohio Northern University, College of Pharmacy, Kisor D (PI) Protocol #1004
• Co-Investigator: Continuous infusion diltiazem for treatment of multifocal atrial tachycardia. Akron General Medical Center, Departments of Internal Medicine and Pharmacy Service. Chapman Critical Care Research Foundation
• Co-Investigator: Prospective, randomized study of continuous intravenous infusion lorazepam versus intermittent intravenous injection for sedation of the critically ill. Akron General Medical Center, Departments of Internal Medicine and Pharmacy Services
• Co-Investigator: Measuring gastric pH control with nasogastric administration of omeprazole vs ranitidine using a pH sensor nasogastric tube in ICU patients. Akron General Medical Center, Departments of Internal Medicine and Pharmacy Service. Chapman Critical Care Research Foundation.
• Co-Investigator: Double-blind comparison of gastric pH control with continuous versus bolused famotidine infusion. Akron General Medical Center, Departments of Medicine and Pharmacy Service. Chapman Critical Care Research Foundation
• Co-Investigator: Correlation between Kirby-Bauer disk diffusion susceptibility testing, minimum inhibitory concentration and clinical outcome in Escherichia coli infections treated with TimentinR. Institutes for Microbiology Research, Akron City Hospital, Departments of Pharmacy and Medicine
• Principle Investigator: Study of predisposing factors and antibiotic use in nosocomial infections caused by Xanthomonas maltophlia. Akron City Hospital, Departments of Pharmacy and Medicine

Hospital Appointments:

• Clinical Pharmacist, University Hospitals of Cleveland, Family Practice Center, 1994 to present
• Pharmacotherapy Specialist in Internal Medicine, Akron General Medical Center, Department of Pharmacy Services, Akron, OH, 1991-1994
• Clinical Coordinator, Summa Health System, Akron City Hospital, Department of Pharmacy Services, Akron, OH, 1989-1991

Partial List of Presentations:

• Invited Presentations (abbreviated since 1999)
  Advancements in the management of inflammatory bowel disease. Northwest Pennsylvania Society of Health-System Pharmacists Annual Meeting. Erie, PA, November 1, 2008.
• Getting things moving: optimal treatment of chronic constipation in managed care. The Academy of Managed Care Pharmacy, Annual Meeting, Boston, MA, October 25, 2007.
• Avoiding drug toxicity in the elderly. Parma General Medical Center. Medical Staff CME Meeting, Parma, OH, April 23, 2008.
• Improving quality of life in the elderly: Optimal treatment of chronic geriatric disorders. University Learning Systems, Inc. Niagra Falls, NY, September 11, 2008.
• Osteoporosis treatment & prophylaxis. Northern Ohio Academy of Pharmacy CE Meeting. Cleveland, OH, October 29, 2008
• New drug update 2008. Northern Ohio Academy of Pharmacy CE Meeting. Cleveland, OH, May 28, 2008.
• Type 2 diabetes: 2008 ADA practice guidelines & novel insulin products. Northern Ohio Academy of Pharmacy. Cleveland, OH, February 27, 2008.
• Update in hypertension treatment. Northern Ohio Academy of Pharmacy. Cleveland, OH, January 30, 2008.
• Treatment of idiopathic chronic constipation. Northern Ohio Academy of Pharmacy. Cleveland, OH, October 31, 2007.
• Pharmacotherapy for overactive bladder. Northern Ohio Academy of Pharmacy. Cleveland, OH, May 30, 2007.
• New understanding of sleep science & therapeutic targets. West Shore Pharmaceutical Association. Cleveland, OH. April 10, 2007.
• Metabolic syndrome & Type II diabetes. West Shore Pharmaceutical Association. Strongsville, OH. November 14, 2006.
• Update on intensive management of Type 2 diabetes: role of insulin. Kappa Epsilon Women's Pharmaceutical Fraternity CE Program, Cleveland, OH, May 22, 2004.
• Cardiovascular & pain medications: Implications for physical & occupational therapists. Visiting Nurses Association CE Conference, Cleveland, OH, March 19-20, 2008.
• GERD: Therapeutic update for Advanced Nurse Practitioners. PBS, Inc Annual Meeting. Beachwood, OH, May 6, 2005
• Drug dosing in the geriatric population. University Hospitals, Case Medical Center CME Teleconference Series. Cleveland, OH, May 16, 2007.
• Polypharmacy in the elderly. Parma General Medical Center. Medical Staff CME Meeting. Parma, OH. March 14, 2007.
• Opiates A-to-Z clinical pharmacology. 4PCP Physician CME meeting. Bratenahl, OH. February 28, 2007
• Evidence-based on dyslipidemia treatment: safety concerns with statin therapy. Cleveland Academy of Family Physicians Annual CME Meeting. Cleveland OH. November 9, 2005.
• Dyslipidemia treatment update for pharmacists. Northern Ohio Academy of Pharmacy, Cleveland, OH, May 31, 2006.
• New treatment options in the management of asthma. West Shore Pharmaceutical Association CE Meeting, Strongsville, OH, May 11, 2004.
• Implementation of an educational program to enhance pharmacy students’ skills in helping children from families with substance abuse. American Society of Health-System Pharmacist Midyear Clinical Meeting. Orlando, FL, December 8, 2004.
• Liver function monitoring and drug-induced hepatotoxicty. Akron Area Society of Health-System Pharmacists CE Meeting, Canton, OH, January 13, 2004.
• Metabolic syndrome, Type 2 diabetes and insulin-sensitizing agents. West Shore Pharmaceutical Association CE Meeting, Olmsted Falls, OH, March 9, 2004.
• A multidisciplinary, interactive electronic instructional unit in substance abuse education. Association for Medical Education and Research in Substance Abuse Annual Meeting, Baltimore, MD, November 7, 2003.
• Clinical pharmacology of drugs for dyslipidemia. University Suburban Health Center CME Conference, South Euclid, OH, May 16, 2002.
• Proton pump inhibitor comparison for reflux esophagitis. Cleveland Society of Health-System Pharmacists. Independence, OH, September 25, 2002.
• Update on hormone replacement therapy and botanical agents for menopause. North Central Ohio Academy of Pharmacy. Mansfield, OH, April 18, 2002.
• Anti-inflammatory therapy for asthma. Lorain County Pharmacists Academy CE Meeting. Elyria, OH, March 19, 2002.
• Popular herbs and dietary supplements: where is the evidence? Northeastern Ohio Academy of Pharmacy CE Meeting, Ashtabula, OH, March 12, 2002.
• Cardiovascular disease prevention and the NCEP/ATP-III guidelines. Lorain County Pharmacists Academy CE Meeting. Elyria, OH, September 18, 2001.
• Multidisciplinary, interactive electronic instruction in substance abuse. Association of Schools of Allied Health Professions Annual Meeting. Toronto, Ontario, October 18, 2003.
• COX-II and non-opioid pharmacological approaches to pain management. CWRU, Department of Continuing Medical Education, Pain Management CME Course, October 5, 2001.
• Safe medication prescribing in pregnancy and lactation. Department of Internal Medicine, Women's Heath Conference, Department of Veterans Affairs, Cleveland, OH, August 15, 2001.
• Screening for erectile dysfunction by Doctor of Pharmacy students in an urban family practice population. American Society of Health-System Pharmacists Midyear Clinical Meeting, New Orleans, LA, December 3, 2001.
• Defining pharmacist's roles in problem analgesic use. American Society of Health-System Pharmacists Midyear Clinical Meeting, New Orleans, LA, December 3, 2001.
• Safe medication prescribing in pregnancy and lactation. National Women's Health Conference, Department of Veterans Affairs, Columbus, OH, September 28, 2000.
• Pharmacological considerations in the management of chronic pain. American Association of Osteopathy Annual Meeting, Cleveland, OH, March 26, 2000.
• Identification of high-risk NSAID users from a family practice clinic population. American Society of Health-System Pharmacists Midyear Clinical Meeting, Orlando, FL, December 6, 1999.
• Pharmacological strategies for weight management. Ohio College of Clinical Pharmacy Annual Scientific Symposium. Westlake, OH, May 5, 2000.
• What's new in drug therapy for obesity. Ohio Pharmacists Association Midyear Meeting, Columbus, OH, November 7, 1999.
• Overview of the COX-II selective inhibitors. Illinois Pharmacists Association Annual Fall Meeting. Chicago, IL, September 24, 1999.
• Antihypertensive agents: evidence-based update. Society of Teachers of Family Medicine Annual Predoctoral Education Conference. Savannah, GA, February 5, 1999.
• Update on the comprehensive management of COPD for Advanced Nurse Practitioners. PBS, Inc Annual Meeting. Beachwood, OH, May 15, 2009.
• Advancements in the management of inflammatory bowel disease. Northwest Pennsylvania Society of Health-System Pharmacists Annual Meeting. Erie, PA, November 1, 2008.
• Safe medication use during pregnancy & lactation. Westshore Pharmaceutical Association CE Meeting, Strongsville, OH, April 14, 2009.
• Glucosamine supplement use by African-American patients in an inner city Family Medicine group practice (poster). Ohio Academy of Family Practice, Symposium on Research & Education. Newark, OH. April 18, 2009.

Awards:

• The Ray Kiwala Distinguished Faculty Award Case Western Reserve University School of Medicine, Department of Family Medicine, 2000-2001
• Kenneth G. Reeb, MD Excellence in Teaching Award University Hospitals Health System, Cleveland, Ohio, Residency Program in Family Medicine, 2000-2001
• Director's Award for Outstanding Achievement University Hospitals Health System, Cleveland, Ohio, Residency Program in Family Medicine, 1999-2000

Home

About

Help

Feedback

Site Map

Newsletter

Search   Advanced

This page is: Yes No Not Sure easy to read easy to understand helpful

Please note: only your personal physician or other health professional you consult can best advise you on matters of your health based on your medical history, your family medical history, your medication history, and how information from any of these databases may apply to you. Neither University of Cincinnati (NetWellness) nor any party involved in creating, producing or delivering this web site shall be liable for any damages arising out of access to or use of this web site, or any errors or omissions in the content thereof. (More) Copyright ® 2009 University of Cincinnati